(Total Views: 551)
Posted On: 05/08/2020 12:45:35 AM
Post# of 145247
Re: jimnordonmd #32811
I'm doubtful. In my experience with other clinical trials, management is usually blinded until the very end of the trial. A third party advisory panel is usually convened to oversee interim looks. I don't believe they share it with management.
(0)
(0)